Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- Check6 days agoChange DetectedNew revision entry v3.6.4 appears in the Study Record History, replacing the previous v3.6.3 and indicating an update to the record's documentation. This update is a version bump in the history rather than a substantive change to the study content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.6.3 is shown, replacing the previous v3.6.2. This reflects an update to the page's software build rather than changes to trial content.SummaryDifference0.1%

- Check34 days agoChange DetectedA new revision entry v3.6.2 was added to the record history. The previous revision v3.6.0 was removed from the history.SummaryDifference0.1%

- Check49 days agoChange DetectedAdds a note that the study is no longer looking for participants. Updates the record version to v3.6.0 and removes the previous v3.5.5 revision tag.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, representing a minor update to the page history system.SummaryDifference0.1%

- Check77 days agoChange DetectedA new version entry (Version 41) was added to the study's record history with a submission date of 2026-05-07 and a Revision: v3.5.4. The prior Revision: v3.5.3 entry, dated 2026-01-30, was removed from the history.SummaryDifference0.3%

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.